Study of Methotrexate in Lupus Erythematosus

NCT00470522 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Methotrexate and folic acid

Sponsor

University Health Network, Toronto

Collaborators

[object Object]